Skip to main content
. 2021 Jan 3;49(1):135–144. doi: 10.1007/s15010-020-01559-5

Table 1.

Demographic data and clinical outcomes of 187 patients with necrotizing fasciitis between the three groups

Variable Group Na
(n = 111)
Group Sb
(n = 35)
Group Hc
(n = 41)
Age (years) 64.0 ± 15.5 68.4 ± 10.8 70.3 ± 13.7†
Gender, male 75 (67.6) 22 (62.9) 27 (65.9)
APACHEd II score 11.5 ± 5.1 14.9 ± 5.8† 16.8 ± 5.3†
Involved lower extremities 66 (59.5) 20 (57.1) 33 (80.5)†§
Seawater, seafood contact history or exposure to farm 46 (41.4) 14 (40.0) 15 (36.6)
Underlying chronic diseases
Alcoholism 27 (24.3) 5 (14.3) 8 (19.5)
Chronic liver dysfunction 34 (30.6) 16 (45.7) 20 (48.8)†
HBV infection 18 (16.2) 5 (14.3) 8 (19.5)
HCV infection 22 (19.8) 12 (34.3) 15 (36.6)†
Liver cirrhosis 25 (22.5) 7 (20.0) 9 (22.0)
Chronic kidney disease 26 (23.4) 8 (22.9) 17 (41.5)†
Cardiovascular disease 18 (16.2) 5 (14.3) 10 (24.4)
Cerebrovascular accident 3 (2.7) 2 (5.7) 6 (14.6)†
Diabetes mellitus 46 (41.4) 14 (40.0) 18 (43.9)
Gout 6 (5.4) 5 (14.3) 1 (2.4)
Malignancy 15 (13.5) 5 (14.3) 11 (26.8)†
Peripheral vascular disease 4 (3.6) 0 (0) 2 (4.9)
Clinical outcomes
Mortality 10 (9.0) 5 (14.3) 7 (17.1)
Amputation 6 (5.4) 2 (5.7) 7 (17.1)†
Mortality or amputation 14 (12.6) 7 (20) 13 (31.7)†
Postoperative intubation 11 (9.9) 5 (14.3) 16 (39.0)†
Need ICUe care 33 (29.7) 12 (34.3) 23 (56.1)†§
Number of debridements 2.6 ± 1.3 2.7 ± 1.3 3.2 ± 1.9†
Hospital stay (days) 31.1 ± 17.1 37.9 ± 28.6 36.7 ± 20.7

Data were presented as mean (standard deviation) or frequency (%). * p-value < 0.05

Abbreviations: aGroup N: no bullae group, bGroup S: serous-filled bullae group, cGroup H: hemorrhagic bullae group, dAPACHE Acute Physiology and Chronic Health Evaluation, eICU intensive unit care. Data were presented as mean (standard deviation); Data were compared with ANOVA, †p < 0.05 vs. no bullae in the Tukey post hoc test; §p < 0.05 vs. serious bullae in the Tukey post hoc test